Biomerica Inc (BMRA) Stock Price, Quote & News

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 645 2111

Fax: 949 553 1231

Website: www.biomerica.com

Address:

17571 Von Karman Avenue, Irvine, United States

BillionerOfKing Nov. 6 at 2:22 PM

$BMRA Current Stock Price: $2.56 No options data available.

0 · Reply

Hurtadogoalkeeper Nov. 6 at 1:38 PM

$BMRA https://www.zacks.com/stock/news/2786515/will-qs-extended-cash-runway-through-2029-fuel-its-next-growth-phase?cid=sm-stocktwits-2-2786515-teaser-19725&ADID=SYND_STOCKTWITS_TWEET_2_2786515_TEASER_19725

0 · Reply

TammyHansen382 Oct. 28 at 5:47 PM

$BMRA detecting health threats; AITX detecting safety threats — the Taylor PD pilot shows how AI can respond before danger escalates.

0 · Reply

counter Oct. 23 at 9:33 PM

$YDKG $BMRA NO!,,,YOUR the DUMB ASS for coming in here and calling people names trying to do their best INSTEAD of helping posting possibilities via charts-your DEFIANTLY young-you can see it a mile away-testosterone fear of being wrong-always has to be right to look like a BIG MAN in front of his peers...if you were in Fallujah-I would NEVER have covered you being such an ass!

1 · Reply

counter Oct. 23 at 9:13 PM

$YDKG THIS is why...was one of BEST calls...$BMRA ...pattern recognition...do you actually know how to read a chart...or draw an analysis?

0 · Reply

DunbPuck Oct. 22 at 2:44 PM

$BMRA let's get it

0 · Reply

Hurtadogoalkeeper Oct. 21 at 5:44 PM

$BMRA

0 · Reply

16Zx10r Oct. 20 at 6:53 PM

$BMRA Let me get that $3.05-$3.10 buy range....

0 · Reply

pigachu69 Oct. 20 at 3:09 PM

$BMRA after a big dip, its going up. $3.20 already

0 · Reply

JL_TradeZ Oct. 20 at 3:08 PM

🚨(SPECIAL PLAY) $BMRA is slowly heating up again after that Henry Schein partnership news. Float is tiny at 2.8M with insiders owning over 90%, which explains how easily it can moves on light volume. Technically, it’s curling over all EMAs and holding above VWAP with RSI showing strong momentum without being overbought yet. If buyers keep stepping in, this could see a squeeze really soon

0 · Reply

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Oct 16, 2025, 8:19 AM EDT - 4 weeks ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Oct 15, 2025, 9:27 AM EDT - 4 weeks ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Oct 8, 2025, 8:19 AM EDT - 5 weeks ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Sep 9, 2025, 8:08 AM EDT - 2 months ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Sep 3, 2025, 8:19 AM EDT - 2 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Aug 29, 2025, 5:12 PM EDT - 2 months ago

Biomerica Reports Fiscal 2025 Year End Results

Aug 14, 2025, 8:19 AM EDT - 3 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

Jul 2, 2025, 8:08 AM EDT - 4 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jun 26, 2025, 8:19 AM EDT - 5 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 6, 2025, 9:30 AM EDT - 5 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 5, 2025, 8:19 AM EDT - 5 months ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

May 22, 2025, 8:19 AM EDT - 6 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 7, 2025, 8:19 AM EDT - 6 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

Apr 23, 2025, 8:19 AM EDT - 7 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 17, 2025, 8:19 AM EDT - 7 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 16, 2025, 9:00 AM EDT - 7 months ago

Biomerica Announces Reverse Stock Split

Feb 26, 2025, 8:19 AM EST - 9 months ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 19, 2025, 8:19 AM EST - 9 months ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Jan 16, 2025, 10:49 AM EST - 10 months ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 8:19 AM EST - 10 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 15, 2025, 8:19 AM EST - 10 months ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Nov 21, 2024, 8:19 AM EST - 1 year ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 7, 2024, 9:09 AM EST - 1 year ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Oct 30, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Sep 4, 2024, 8:19 AM EDT - 1 year ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results

Jul 1, 2024, 7:47 AM EDT - 1 year ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

May 13, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Apr 29, 2024, 8:19 AM EDT - 1 year ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 15, 2024, 7:47 AM EDT - 1 year ago

Biomerica provides update on inFoods® IBS expansion

Apr 12, 2024, 7:23 PM EDT - 1 year ago

Biomerica Reports Third Quarter 2024 Financial Results

Mar 28, 2024, 8:19 AM EDT - 1 year ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Feb 21, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Jan 23, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 16, 2024, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter 2024 Financial Results

Dec 18, 2023, 7:47 AM EST - 2 years ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Nov 10, 2023, 8:19 AM EST - 2 years ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 8, 2023, 8:19 AM EST - 2 years ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Oct 13, 2023, 1:10 PM EDT - 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

Sep 26, 2023, 8:19 AM EDT - 2 years ago

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Aug 28, 2023, 8:19 AM EDT - 2 years ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Aug 25, 2023, 5:00 PM EDT - 2 years ago

Biomerica Reports Fiscal 2023 Year End Results

Aug 3, 2023, 8:19 AM EDT - 2 years ago

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Jun 21, 2023, 8:19 AM EDT - 2 years ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

May 18, 2023, 8:19 AM EDT - 2 years ago

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Apr 17, 2023, 7:47 AM EDT - 2 years ago

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Apr 14, 2023, 4:48 PM EDT - 2 years ago

Biomerica Reports Q3 Fiscal 2023 Results

BillionerOfKing Nov. 6 at 2:22 PM

$BMRA Current Stock Price: $2.56 No options data available.

0 · Reply

Hurtadogoalkeeper Nov. 6 at 1:38 PM

0 · Reply

TammyHansen382 Oct. 28 at 5:47 PM

$BMRA detecting health threats; AITX detecting safety threats — the Taylor PD pilot shows how AI can respond before danger escalates.

0 · Reply

counter Oct. 23 at 9:33 PM

1 · Reply

counter Oct. 23 at 9:13 PM

$YDKG THIS is why...was one of BEST calls...$BMRA ...pattern recognition...do you actually know how to read a chart...or draw an analysis?

0 · Reply

DunbPuck Oct. 22 at 2:44 PM

$BMRA let's get it

0 · Reply

Hurtadogoalkeeper Oct. 21 at 5:44 PM

$BMRA

0 · Reply

16Zx10r Oct. 20 at 6:53 PM

$BMRA Let me get that $3.05-$3.10 buy range....

0 · Reply

pigachu69 Oct. 20 at 3:09 PM

$BMRA after a big dip, its going up. $3.20 already

0 · Reply

JL_TradeZ Oct. 20 at 3:08 PM

0 · Reply

ChaseDeluca Oct. 20 at 1:52 PM

$VRME just the start of a super nova run!🚨🚨🚨 $BYND $OPEN $BETR $BMRA

0 · Reply

orelorel_ Oct. 20 at 8:08 AM

$BMRA Today is going to be interesting prices...🌐

0 · Reply

Greatviews Oct. 19 at 12:45 PM

$BMRA isn’t exactly blowing the doors with sales so why would they need an agreement with Henry Schein? Things that make you go hmmmm…..

1 · Reply

alma356m Oct. 17 at 8:05 PM

$BMRA Ends with a green hammer candlestick. A bullish sign.

0 · Reply

alma356m Oct. 17 at 7:58 PM

$BMRA Look what happen a couple of days ago during post market. about 1.69M shares traded.....usually don't see that kind of action during post market....something is up.

0 · Reply

makedatbread88 Oct. 17 at 7:21 PM

$BMRA had news yesterday but no move with a low float Keep an eye here

0 · Reply

alma356m Oct. 17 at 6:14 PM

$BMRA put this one on your watchlist!

0 · Reply

alma356m Oct. 17 at 6:13 PM

$BMRA here is another one. This may explain why after hours a couple days ago it went up so high good things are happening behind the scenes! https://stockanalysis.com/stocks/bmra/

0 · Reply

alma356m Oct. 17 at 6:10 PM

$BMRA here is another one that’s not posted in stock twits news:

0 · Reply

alma356m Oct. 17 at 6:08 PM

$BMRA I wonder why Stocktwits 24 did not post this in their news folder? It was released yesterday!

0 · Reply

Expenslvetaste Oct. 17 at 3:21 PM

$BMRA stock is boring and this board is boring!

1 · Reply

Expenslvetaste Oct. 17 at 9:33 AM

$BMRA

2 · Reply

Market Cap	7.11M
Revenue (ttm)	5.31M
Net Income (ttm)	-4.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-93.60%
Debt to Equity Ratio	0.00

Volume	17,300
Avg Vol	126,220
Day's Range	N/A - N/A
Shares Out	2.95M
Stochastic %K	15%
Beta	0.28
Analysts	Strong Buy
Price Target	$13.00